Amavita has started using AISAP’s AI-powered POCUS diagnostic in community settings for aortic stenosis screening.
The company is currently preparing for Phase III trials to further assess the efficacy and safety of the agent in identifying active inflammation in individuals with Crohn's disease. Credit: ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果